Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica.
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- Это наблюдательное исследование: исследуемое лечение участникам по протоколу не назначают.
- Кому может быть актуально
- Состояния в реестре: Lymph Node Cancer, Cutaneous, T-cell Lymphoma. Базовые параметры: от 18 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Costa Rica
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
Epidemiological Profile and Therapeutic Management of Patients Diagnosed With Cutaneous T-cell Lymphoma Evaluated in the Dermatology Department of Hospital México During the Period From 2019 to 2025.
Обзор
Adult patients (≥18 years) with confirmed cutaneous T-cell lymphoma evaluated at Hospital México between 2019 and 2025 will be retrospectively analyzed using EDUS records to describe their epidemiological profile, clinical characteristics, treatments, and outcomes.
Подробное описание
This retrospective observational study will analyze adult patients (≥18 years) with a confirmed diagnosis of cutaneous T-cell lymphoma evaluated in the Dermatology Service of Hospital México between January 2019 and December 2025. Data will be obtained from electronic medical records (EDUS), including sociodemographic characteristics, clinical presentation, histopathological and immunohistochemical findings, disease staging, treatment modalities, and clinical outcomes.
Patients must have at least one documented dermatological evaluation and have received treatment, including skin-directed therapies and/or systemic therapies. Records that are incomplete, inconsistent, or lack histopathological confirmation will be excluded.
The study aims to characterize local epidemiological and therapeutic patterns and describe clinical outcomes using descriptive statistical analysis, providing updated real-world evidence to support clinical decision-making and optimize management strategies for cutaneous T-cell lymphoma in a national referral center.
Первичные конечные точки
- Characterize the epidemiology [Срок оценки: 2019-2025]
- Characterize the therapeutic management [Срок оценки: 2019-2025.]
Вторичные конечные точки (7)
- Describe the sociodemographic/epidemiological characteristics [Срок оценки: 2019-2025]
- Classify the clinical manifestations/clinical subtypes [Срок оценки: 2019-2025]
- Identify the histopathological/ immunohistochemical findings [Срок оценки: 2019-2025]
- Analyze the therapeutic management modalities. [Срок оценки: 2019-2025]
- identify the clinical stage at the time of diagnosis [Срок оценки: 2019-2025]
- Evaluation of imaging studies and laboratory. [Срок оценки: 2019-2025]
- Evaluation of clinical course and outcomes. [Срок оценки: 2019-2025]
Критерии участия
Критерии включения
- Patients with a confirmed diagnosis of cutaneous T-cell lymphoma, established through clinical, histopathological, and immunohistochemical criteria, documented in EDUS of Hospital México in the Dermatology Service of Hospital México during the period between January 2019 and December 2025.
- Patients aged 18 years or older, of both sexes.
- Patients with at least one dermatological evaluation recorded during the study period.
- Patients who, having a confirmed diagnosis, have received some modality of treatment, including skin-directed therapies (phototherapy, topical treatments, localized radiotherapy) and/or systemic treatments.
Критерии исключения
- Clinical records that are insufficient or incomplete, preventing adequate diagnostic classification, staging, therapeutic characterization, or evaluation of clinical evolution.
- Patients with a presumptive diagnosis of cutaneous T-cell lymphoma without histopathological confirmation.
- Duplicate or inconsistent records that hinder the correct identification and classification of the patient.
- Patients attended outside the established study period.
- Patients outside the age range.
- Patients who do not belong to the Dermatology Service of Hospital México.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Модель наблюдения
- Когортное
Центры проведения
Costa Rica · 1 центр
- Hospital México — San José
Идентификаторы
NCT: NCT07538960 · CEC HM 002-2026